Advertisement

Jansen Jab Gets The EMA’s Go Ahead

The benefits of the Johnson & Johnson Covid-19 vaccine outweigh the risks - that’s what the...

Share this article

09.41 21 Apr 2021


Jansen Jab Gets The EMA’s Go Ahead


Listen to this episode


Share this article

09.41 21 Apr 2021


The benefits of the Johnson & Johnson Covid-19 vaccine outweigh the risks - that’s what the European Medicines Agency concluded yesterday. Concerns about the Jansen jab’s safety had been raised following reports of a small number of blood clots in US recipients. Professor of Experimental Immunology at Trinity College Dublin, Kingston Mills joined us this morning.

Listen and subscribe to Newstalk Breakfast on Apple Podcasts or Spotify.

   

Download, listen and subscribe on the Newstalk App.

  

You can also listen to Newstalk live on newstalk.com or on Alexa, by adding the Newstalk skill and asking: 'Alexa, play Newstalk'.


Read more about

Breakfast Covid Vaccine Jansen Vaccine Johnson And Johnson Newstalk Newstalk Breakfast Vaccine

Related Episodes

Why are Gen Z having less sex...

00:10:13

Why are Gen Z having less sex then previous generations ?

Lunchtime Live

00:10:13


Reasons to be Happy: Derelict...

00:08:21

Reasons to be Happy: Derelict Aran Island hotel to reopen, Translating human speech into dog language and the Six Nations is back!

Lunchtime Live

00:08:21


Who is going to mind them ?  E...

00:25:33

Who is going to mind them ? Elderly parents caring for adult children with disabilities worry about their future without them.

Lunchtime Live

00:25:33


Making Babies: What to do if y...

00:09:43

Making Babies: What to do if your baby requires Neonatal care ?

Lunchtime Live

00:09:43